Topical ketoprofen TDS patch versus diclofenac gel: Efficacy and tolerability in benign sport related soft-tissue injuries

British Journal of Sports Medicine

Volumn 41, Issue 3, 2007, Pages 134-139

  Esparza, Francisco ^a,b   Cobián, César ^c   Jiménez, José Fernando ^d   García Cota, Juan José ^e   Sánchez, Carlos ^f   Maestro, Antonio ^g,h  

^a Facultad de Ciencias de la Salud y Del Deporte   (Spain)

^b Centro Médico Juan XXIII   (Spain)

^c Hospital HM Modelo   (Spain)

^d Centro de Medicina General Y Deporte   (Spain)

^e Hospital Miguel Domínguez   (Spain)

^f Servicios Médicos de la Autoridad Portuaria de Valencia   (Spain)

^g Hospital Begoña   (Spain)

^h SETRADE (Spanish Society of Sports Traumatology)   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

DICLOFENAC; DOLOTREN; KETOPROFEN; PARACETAMOL; UNCLASSIFIED DRUG;

AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTUSION; DEMOGRAPHY; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM; DRUG EFFICACY; DRUG TOLERABILITY; ERYTHEMA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PAIN; PATIENT COMPLIANCE; PHASE 2 CLINICAL TRIAL; PHYSICAL STRESS; RANDOMIZED CONTROLLED TRIAL; SOFT TISSUE INJURY; SPORT INJURY; SPRAIN; UNSPECIFIED SIDE EFFECT; VISUAL ANALOG SCALE;

ADMINISTRATION, TOPICAL; ADOLESCENT; ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ATHLETIC INJURIES; DICLOFENAC; FEMALE; GELS; HUMANS; KETOPROFEN; MALE; MIDDLE AGED; PAIN; PROSPECTIVE STUDIES; SOFT TISSUE INJURIES; TREATMENT OUTCOME;

EID: 34147223538     PISSN: 03063674     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjsm.2006.030239     Document Type: Article

References (23)

1. Nicholl JP, Coleman P, Williams BT. The epidemiology of sports and exercise related injury in the United Kingdom. Br J Sports Med 1995;29:232-8.
2. Menasse R, Hedwall PR, Kraetz J, et al. Pharmacological properties of diclofenac sodium and its metabolites. Scand J Rheumatol 1978;22 Suppl:5-16.
3. Maier R, Menasse R, Rieslerer L, et al. The pharmacology of diclofenac sodium (Voltarol). Rheumatol Rehabil 1979;Suppl 2:11-21.
4. Ogilvie-Harris DJ, Gilbart M. Treatment modalities for soft tissue injuries of the ankle: a critical review. Clin J Sport Med 1995;5:175-86.
5. Burnham R, Gregg R, Healy P, et al. The effectiveness of topical diclofenac for lateral epicondylitis. Clin J Sport Med 1998;8:78-81.
6. Galer BS, Rowbotham M, Perander J, et al. Topical diclofenac patch relieves minor sports injury pain: results of a multicenter controlled clinical trial. J Pain Symptom Manage 2000;19:287-94.
7. Singh P, Roberts MS. Skin permeability and local tissue concentrations of nonsteroidal anti-inflammatory drugs after topical application. J Pharmacol Exp Ther 1994;268:144-51.
8. Heyneman CA, Lawless-Liday C, Wall GC. Oral versus topical NSAIDs in rheumatic diseases: a comparison. Drugs 2000;60:555-74.
9. Moore RA, Tramer MR, Carroll D, et al. Quantitative systematic review of topically applied non-steroidal anti-inflammatory drugs. BMJ 1998;316:333-8.
10. SGS Lab. Simon (reference S 100 712). Determination of acute dermal irritation of a ketoprofen TDS patch. Report on file. September, 2000.
11. SGS Lab. Simon (reference S 100 713). Determination of acute ocular irritation of a ketoprofen TDS patch. Report on file. October, 2000.
12. SGS Lab. Simon (reference S 100 711). Determination of skin sensitization of a ketoprofen TDS patch. Report on file. November, 2000.
13. SGS Lab. Simon (reference S 100 714). Determination of repeated skin irritation of a ketoprofen TDS patch. Report on file. December, 2000.
14. Labtec GmbH. In vitro percutaneous absorption in hairless mouse skin in comparison with ketoprofen patch (30 mg/70 cm2) and 2.5% ketoprofen gel (Gabrilen®), Report on file. May 1997.
15. Klaffenbach P, Wollmer U. In vitro percutaneous absorption in human isolated skin: test-product ketoprofen TDS patch in comparison with ketoprofen gel, Report on file. September 2000.
16. SGS Biopharma (reference B 100 577). In vivo transdermal absorption of ketoprofen (ketoprofen TDS patch v. ketoprofen gel) after a single administration in 12 rabbits. Report on file. March, 2001.
17. Bouchier-Hayes TA, Rotman H, Darekar BS. Comparison of the efficacy and tolerability of diclofenac gel (Voltarol Emulgel) and felbinac gel (Traxam) in the treatment of soft tissue injuries. Br J Clin Pract 1990;44:319-20.
18. Radermacher J, Jentsch D, Scholl MA, et al. Diclofenac concentrations in synovial fluid and plasma after cutaneous application in inflammatory and degenerative joint disease. Br J Clin Pharmacol 1991;31:537-41.
19. Ritchie ID. A clinical evaluation of flurbiprofen LAT and piroxicam gel: a multicentre study in general practice. Clin Rheumatol 1996;15:243-7.
20. Mazieres B, Rouanet S, Guillon Y, et al. Topical ketoprofen patch in the treatment of tendinitis: a randomized, double blind, placebo controlled study. J Rheumatol 2005;32:1563-70.
21. Mazieres B, Rouanet S, Velicy J, et al. Topical ketoprofen patch (100 mg) for the treatment of ankle sprain: a randomized, double-blind, placebo-controlled study. Am J Sports Med 2005;33:515-23.
22. Patel RK, Leswell PF. Comparison of ketoprofen, piroxicam, and diclofenac gels in the treatment of acute soft-tissue injury in general practice. General Practice Study Group. Clin Ther 1996;18:497-507.
23. Galer BS, Rowbotham M, Perander J, et al. Topical diclofenac patch relieves minor sports injury pain: results of a multicenter controlled clinical trial. J Pain Symptom Manage 2000;19:287-94.